@ShahidNShah
How digital therapeutics can go mainstream in fragmented U.S. healthcare
There are many stakeholders interested in digital therapeutics, but aligning under the common goal of patient needs is key.
Over the last decade, digital therapeutics have been gaining steam. In part, this shift is aided by the adoption of connected medical tools during the COVID-19 pandemic and the ongoing push toward more of a hybrid care model. However, the technologies have largely not yet hit the mainstream market.
Today, industry players are looking to get stakeholders from the provider, payer and life science industries onboard.
Continue reading at mobihealthnews.com
Make faster decisions with community advice
- 29 physician specialties ranked by annual compensation
- How to successfully ensure data privacy and security to transform healthcare?
- How voice recognition technology is improving the patient caller experience
- ONC announces new interoperability program for federal partners
- Why Healthcare IT Must Embrace Full-Stack Observability for an Increasingly Digital Future
Next Article
-
How to successfully ensure data privacy and security to transform healthcare?
Learn why organizations need to put patient data privacy and security first and what actionable steps can help to ensure it. As technology advances and the potential of data to transform healthcare …
Posted Oct 9, 2021 Data Privacy